Due to the special nature of medicines, returns and exchanges are not supported.

Final delivery from the nearest overseas warehous NEW

LORBRENA（Lorlatinib）劳拉替尼

Treatment of ALK whose disease has progressed after treatment with crizotinib and at least one other ALK inhibitor, or after treatment with alectinib or ceritinib as the first ALK inhibitor Positive metastatic non-small cell lung cancer (NSCLC) patients.

Categories: Oncology drugs, respiratory/skeleton system

Share:

Our offers

Saving your money for next purchases

Delivery – when you want and anywhere

A huge selection of best products

Health Classification

Let us work together to protect precious health

More